Old Web
English
Sign In
Acemap
>
authorDetail
>
Wolf-Dieter Ludwig
Wolf-Dieter Ludwig
German Medical Association
Medicine
Immunology
Pathology
Clinical trial
Insulin-like growth factor
5
Papers
141
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (5)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
The role of simulated-experience and descriptive formats on perceiving risks of strong opioids: A randomized controlled trial with chronic noncancer pain patients.
2021
Patient Education and Counseling
Odette Wegwarth
Wolf-Dieter Ludwig
Claudia Spies
Erika Schulte
Ralph Hertwig
Show All
Source
Cite
Save
Citations (0)
Suggestions for improving the design of clinical trials in multiple sclerosis—results of a systematic analysis of completed phase III trials
2019
The Epma Journal
Sinje Gehr
Thomas Kaiser
Reinhold Kreutz
Wolf-Dieter Ludwig
Friedemann Paul
Show All
Source
Cite
Save
Citations (21)
Metamizole (dipyrone)-associated agranulocytosis. An analysis of German spontaneous reports 1990–2012
2015
European Journal of Clinical Pharmacology
Thomas Stammschulte
Wolf-Dieter Ludwig
Bernd Mühlbauer
Elisabeth Bronder
Ursula Gundert-Remy
Show All
Source
Cite
Save
Citations (67)
Incidence of thyroid hormone therapy in patients treated with sunitinib or sorafenib: a cohort study.
2012
European Journal of Cancer
Sandra Feldt
Katrin Schüssel
Renate Quinzler
Alexandra Franzmann
Sittah Czeche
Wolf-Dieter Ludwig
Martin Schulz
Show All
Source
Cite
Save
Citations (34)
Characterisation of insulin-like growth factor I receptors of human acute lymphoblastic leukaemia (ALL) cell lines and primary ALL cells
1992
European Journal of Cancer
Thomas G. Baier
Wolf-Dieter Ludwig
D Schönberg
Klaus Hartmann
Show All
Source
Cite
Save
Citations (19)
1